Abstract
Ever since ESA therapy was introduced, clinical practice guidelines on the management of anemia in patients with CKD have been devised in various parts of the world. Thus, US, European, UK (National Institute for Health and Clinical Excellence [NICE]), Australian, Canadian, and Japanese anemia guidelines have all been published over the last two decades. The guidelines have discussed most of the issues outlined in this chapter, focusing mainly on ESA and iron management, and there has been an evolution of recommendations over time. Since 2010, the Work Group of the KDIGO Anemia Guideline has reviewed the latest evidence on the management of anemia in CKD patients, and their final report was published in August 2012.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
NKF-DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis. 1997;30(suppl 3):S192-S240.
Cameron JS. European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol Dial Transplant. 1999;14(suppl 2):61-65.
Barrett BJ, Fenton SS, Ferguson B, et al. Clinical practice guidelines for the management of anemia coexistent with chronic renal failure. Canadian Society of Nephrology. J Am Soc Nephrol. 1999;10(suppl 13):S292-S296.
NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis. 2001;37(suppl 1):S182-S238.
Locatelli F, Aljama P, Barany P, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(suppl 2):ii1-47.
Gejyo F, Saito A, Akizawa T, et al. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients. Ther Apher Dial. 2004;8:443-459.
Pollock C, McMahon L. The CARI guidelines. Biochemical and haematological targets guidelines. Haemoglobin. Nephrology (Carlton). 2005;10(suppl 4):S108-S115.
National Institute for Health and Clinical Excellence. Anaemia management in people with chronic kidney disease. www.nice.org.uk/CG039. Updated March 2012. Accessed February 6, 2013.
National Kidney Foundation. KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis. 2007;50:471-530.
Locatelli F, Aljama P, Canaud B, et al. Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the trial to reduce cardiovascular events with Aranesp therapy (TREAT) study. Nephrol Dial Transplant. 2010;25:2846-2850.
National Institute for Health and Clinical Excellence. Anaemia management in people with chronic kidney disease. http://guidance.nice.org.uk/CG114. Updated November 2012. Accessed February 6, 2013.
National Kidney Foundation. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2:v-335.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Healthcare
About this chapter
Cite this chapter
Macdougall, I.C. (2013). Guidelines on the Management of Renal Anemia. In: Pocket Reference to Renal Anemia. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-48-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-907673-48-1_8
Published:
Publisher Name: Springer Healthcare, Tarporley
Print ISBN: 978-1-908517-74-6
Online ISBN: 978-1-907673-48-1
eBook Packages: MedicineMedicine (R0)